Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Triptorelin, sold under the brand name Decapeptyl among others, is a medication that acts as an agonist analog of gonadotropin-releasing hormone, repressing expression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It was patented in 1975 and approved for medical use in 1986. Triptorelin is a therapeutic alternative on the World…
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Triptorelin.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Triptorelin shows recurring relationship patterns in the source. For example, Triptorelin → Arbor Pharmaceuticals, Decapeptyl, Diphereline, Ferring Pharmaceuticals, Germany, Gonapeptyl, In, In Iran, Ipsen, Salvacyl, Trelstar, Triptodur, UK, United States, Variopeptyl, Watson Pharmaceuticals Another extracted example is Triptorelin → FSH, GnRH, LH, LHRH, The, This. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
hormone used prostate cancer agonist treatment brand 100 50 gonadotropin-releasing drug lh fsh ivf name decapeptyl gnrh acetate names dose
TTTA extracted 68 structured relationships around Triptorelin. Examples in this analysis include Triptorelin → 3D model (JSmol) → Interactive image and Triptorelin → AHFS/Drugs.com → Micromedex Detailed Consumer Information. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Triptorelin | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Triptorelin | AHFS/Drugs.com | Micromedex Detailed Consumer Information | 1.00 | infobox |
| Triptorelin | ATC code | L02AE04 (WHO) QH01CA97 (WHO) | 1.00 | infobox |
| Triptorelin | CAS Number | 57773-63-4 N | 1.00 | infobox |
| Triptorelin | ChEBI | CHEBI:63633 N | 1.00 | infobox |
| Triptorelin | ChEMBL | ChEMBL1201334 N | 1.00 | infobox |
| Triptorelin | ChemSpider | 17290424 N | 1.00 | infobox |
| Triptorelin | CompTox Dashboard (EPA) | DTXSID2048375 | 1.00 | infobox |
| Triptorelin | Drug class | GnRH analogue; GnRH agonist; Antigonadotropin | 1.00 | infobox |
| Triptorelin | DrugBank | DB06825 N | 1.00 | infobox |
| Triptorelin | ECHA InfoCard | 100.165.044 | 1.00 | infobox |
| Triptorelin | Elimination half-life | The elimination half-life for patients with hepatic impairment was similar to that of patients with renal impairment (geometric mean t(1/2, z): 6.6 h, 7.7 h and 7.6 h for Groups… | 1.00 | infobox |
| Triptorelin | Excretion | Kidney | 1.00 | infobox |
| Triptorelin | Formula | C64H82N18O13 | 1.00 | infobox |
| Triptorelin | IUPHAR/BPS | 1177 | 1.00 | infobox |
| Triptorelin | KEGG | D06247 N | 1.00 | infobox |
| Triptorelin | KEGG | D08649 | 1.00 | infobox |
| Triptorelin | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Triptorelin | Legal status | CA: ℞-only | 1.00 | infobox |
| Triptorelin | Legal status | US: ℞-only | 1.00 | infobox |
| Triptorelin | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Triptorelin | License data | US DailyMed: Triptorelin | 1.00 | infobox |
| Triptorelin | Molar mass | 1311.473 g·mol−1 | 1.00 | infobox |
| Triptorelin | PubChem CID | 25074470 | 1.00 | infobox |
| Triptorelin | Routes of administration | Intramuscular | 1.00 | infobox |
| Triptorelin | Trade names | Decapeptyl, others | 1.00 | infobox |
| Triptorelin | UNII | 9081Y98W2V | 1.00 | infobox |
| Triptorelin | is a | therapeutic alternative on the World Health Organization's List of Essential Medicines.It is a decapeptide | 0.90 | text |
The concept neighborhoods around Triptorelin bring nearby vocabulary together. In this analysis, examples include Results, Used and Daily. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Triptorelin, one of the stronger structural bridges in this analysis connects Triptorelin with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Triptorelin to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Triptorelin · EN edition · Analysis: TopicsToTalkAbout